DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance
NCT ID: NCT02403180
Last Updated: 2016-08-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2015-05-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens
NCT01797783
Visual Assessment of DAILIES® AquaComfort Plus® for Astigmatism as Compared to 1-DAY ACUVUE® MOIST® for Astigmatism
NCT02071771
Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric
NCT02289742
Comparison of Two Daily Disposable Lenses
NCT04013789
Clinical Evaluation of DAILIES TOTAL 1® Multifocal Compared to 1-Day Acuvue® Moist® Multifocal in a Japanese Population
NCT03341923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DACP MF, then PROCLEAR 1D MF
DACP MF (nelfilcon A) multifocal contact lenses worn in Period 1, followed by PROCLEAR 1D MF (omafilcon A) multifocal contact lenses worn in Period 2. Both products were worn bilaterally (in both eyes) for 5 ±1 days in a daily wear, daily disposable modality.
DACP MF
Nelfilcon A multifocal contact lenses
PROCLEAR 1D MF
Omafilcon A multifocal contact lenses
PROCLEAR 1D MF, then DACP MF
PROCLEAR 1D MF (omafilcon A) multifocal contact lenses worn in Period 1, followed by DACP MF (nelfilcon A) multifocal contact lenses worn in Period 2. Both products were worn bilaterally (in both eyes) for 5 ±1 days in a daily wear, daily disposable modality.
DACP MF
Nelfilcon A multifocal contact lenses
PROCLEAR 1D MF
Omafilcon A multifocal contact lenses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DACP MF
Nelfilcon A multifocal contact lenses
PROCLEAR 1D MF
Omafilcon A multifocal contact lenses
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adapted soft contact lens wearer;
* Vision correctable to 20/30 \[(0.2 logMAR (logarithm of the minimum angle of resolution)\] or better in each eye at distance;
* Willing to wear lenses every day or for at least 5 days per week, 6 hours per day;
Exclusion Criteria
* Currently wearing monovision;
* Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
* Use of systemic or ocular medications which could contraindicate contact lens wear;
* Eye injury or surgery within 12 weeks prior to enrollment;
* Prior refractive surgery;
* Monocular (only 1 eye with functional vision) or fit with only 1 lens;
41 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Manager
Role: STUDY_DIRECTOR
Alcon, Spain
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLW681-P001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.